BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 30898176)

  • 1. Insulin-like growth factor I, binding proteins -1 and -3, risk of type 2 diabetes and macronutrient intakes in men.
    Similä ME; Kontto JP; Virtamo J; Hätönen KA; Valsta LM; Sundvall J; Männistö S
    Br J Nutr; 2019 Apr; 121(8):938-944. PubMed ID: 30898176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
    Spitz MR; Barnett MJ; Goodman GE; Thornquist MD; Wu X; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor-Binding Protein 3 in Relation to the Risk of Type 2 Diabetes Mellitus: Results From the EPIC-Potsdam Study.
    Drogan D; Schulze MB; Boeing H; Pischon T
    Am J Epidemiol; 2016 Mar; 183(6):553-60. PubMed ID: 26880678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGF-I, IGFBP-3, and IGF-I/IGFBP-3 ratio: no association with incident colorectal cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study.
    Max JB; Limburg PJ; Ogunseitan A; Stolzenberg-Solomon RZ; Vierkant RA; Pollak MJ; Sellers TA; Virtamo J; Cerhan JR; Albanes D
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1832-4. PubMed ID: 18628438
    [No Abstract]   [Full Text] [Related]  

  • 5. Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men.
    Ma J; Giovannucci E; Pollak M; Chan JM; Gaziano JM; Willett W; Stampfer MJ
    J Natl Cancer Inst; 2001 Sep; 93(17):1330-6. PubMed ID: 11535708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
    Jehle PM; Jehle DR; Mohan S; Böhm BO
    J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.
    Frystyk J; Skjaerbaek C; Vestbo E; Fisker S; Orskov H
    Diabetes Metab Res Rev; 1999; 15(5):314-22. PubMed ID: 10585616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary predictors of the insulin-like growth factor system in adolescent females: results from the Dietary Intervention Study in Children (DISC).
    Kerver JM; Gardiner JC; Dorgan JF; Rosen CJ; Velie EM
    Am J Clin Nutr; 2010 Mar; 91(3):643-50. PubMed ID: 20089725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.
    Stattin P; Bylund A; Rinaldi S; Biessy C; Déchaud H; Stenman UH; Egevad L; Riboli E; Hallmans G; Kaaks R
    J Natl Cancer Inst; 2000 Dec; 92(23):1910-7. PubMed ID: 11106682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus.
    Janssen JA; Jacobs ML; Derkx FH; Weber RF; van der Lely AJ; Lamberts SW
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2809-15. PubMed ID: 9284701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.
    Woodson K; Tangrea JA; Pollak M; Copeland TD; Taylor PR; Virtamo J; Albanes D
    Cancer Res; 2003 Jul; 63(14):3991-4. PubMed ID: 12873996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serum retinol and carotenoids with insulin-like growth factors and insulin-like growth factor binding protein-3 among control subjects of a nested case-control study in the Japan Collaborative Cohort Study.
    Suzuki K; Ito Y; Hashimoto S; Kawado M; Inoue T; Ando M; Watanabe Y; Inaba Y; Tajima K; Nakachi K; Tamakoshi A;
    Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():29-35. PubMed ID: 20553078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a high-protein diet on ghrelin, growth hormone, and insulin-like growth factor-I and binding proteins 1 and 3 in subjects with type 2 diabetes mellitus.
    Gannon MC; Nuttall FQ
    Metabolism; 2011 Sep; 60(9):1300-11. PubMed ID: 21406307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition.
    Crowe FL; Key TJ; Allen NE; Appleby PN; Roddam A; Overvad K; Grønbaek H; Tjønneland A; Halkjaer J; Dossus L; Boeing H; Kröger J; Trichopoulou A; Dilis V; Trichopoulos D; Boutron-Ruault MC; De Lauzon B; Clavel-Chapelon F; Palli D; Berrino F; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; Vrieling A; van Gils CH; Peeters PH; Gram IT; Skeie G; Lund E; Rodríguez L; Jakszyn P; Molina-Montes E; Tormo MJ; Barricarte A; Larrañaga N; Khaw KT; Bingham S; Rinaldi S; Slimani N; Norat T; Gallo V; Riboli E; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1333-40. PubMed ID: 19423514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary intake and the insulin-like growth factor system: effects of migration in two related populations in India and Britain with markedly different dietary intake.
    Heald AH; Sharma R; Anderson SG; Vyas A; Siddals K; Patel J; Bhatnagar D; Prabharkaran D; Rudenski A; Hughes E; Durrington P; Gibson JM; Cruickshank JK
    Public Health Nutr; 2005 Sep; 8(6):620-7. PubMed ID: 16236191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.
    Kaaks R; Toniolo P; Akhmedkhanov A; Lukanova A; Biessy C; Dechaud H; Rinaldi S; Zeleniuch-Jacquotte A; Shore RE; Riboli E
    J Natl Cancer Inst; 2000 Oct; 92(19):1592-600. PubMed ID: 11018095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IGF system in patients with type 2 diabetes: associations with markers of cardiovascular target organ damage.
    Hjortebjerg R; Laugesen E; Høyem P; Oxvig C; Stausbøl-Grøn B; Knudsen ST; Kim WY; Poulsen PL; Hansen TK; Bjerre M; Frystyk J
    Eur J Endocrinol; 2017 May; 176(5):521-531. PubMed ID: 28179448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of animal and plant protein intakes with biomarkers of insulin and insulin-like growth factor axis.
    Lee DH; Tabung FK; Giovannucci EL
    Clin Nutr; 2022 Jun; 41(6):1272-1280. PubMed ID: 35504170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
    Vrieling A; Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Keinan-Boker L; van Gils CH; Peeters PH
    Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in insulin-like growth factor-I and its binding proteins are associated with diabetes mellitus in older adults.
    Aneke-Nash CS; Parrinello CM; Rajpathak SN; Rohan TE; Strotmeyer ES; Kritchevsky SB; Psaty BM; Bůžková P; Kizer JR; Newman AB; Strickler HD; Kaplan RC
    J Am Geriatr Soc; 2015 May; 63(5):902-9. PubMed ID: 25989565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.